RGF Capital Markets Valuation

Q: How does 539669's PE Ratio compare to its peers?

Insufficient data to answer this question

Q: How does 539669's PE Ratio compare vs other companies in the IN Diversified Financial Industry?

Insufficient data to answer this question

Q: What is 539669's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to answer this question

Q: What is the Fair Price of 539669 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to answer this question

Q: What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to answer this question

Is 539669 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Share Price vs Fair Value

What is the Fair Price of 539669 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 539669?

Key metric:

The above table shows the Price to Earnings ratio for 539669. This is calculated by dividing 539669's market cap by their current earnings.
What is 539669's PE Ratio?
PE Ratio	58.7x
Earnings	₹1.38m
Market Cap	₹82.51m

539669 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 539669's PE Ratio compare to its peers?

The above table shows the PE ratio for 539669 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	34.3x
506365 Chemo Pharma Laboratories	27.9x	n/a	₹108.0m
540481 Classic Leasing & Finance	25.9x	n/a	₹96.9m
530839 Clio Infotech	27x	n/a	₹59.7m
538918 Vani Commercials	56.4x	n/a	₹138.7m
539669 RGF Capital Markets	58.7x	n/a	₹82.5m

Price to Earnings Ratio vs Industry

How does 539669's PE Ratio compare vs other companies in the IN Diversified Financial Industry?

6 Companies	Price / Earnings	Estimated Growth	Market Cap
531310 Available Finance	1.9x	n/a	US$31.71m
538732 Vibrant Global Capital	4.5x	n/a	US$15.29m
539946 Bazel International	4x	n/a	US$1.79m
538863 Sri Amarnath Finance	3.1x	n/a	US$941.06k

6 Companies		Estimated Growth	Market Cap

No more companies

Price to Earnings Ratio vs Fair Ratio

What is 539669's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

539669 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	58.7x
Fair PE Ratio	n/a

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Discover undervalued companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/03 17:02
End of Day Share Price	2025/02/03 00:00
Earnings	2024/09/30
Annual Earnings	2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

RGF Capital Markets Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution